BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 10604099)

  • 21. [The combined radiochemotherapy of inoperable esophageal neoplasms: a feasibility study].
    Sola B; Airoldi M; Orecchia R; Rovea P; Fracchia F; Boidi Trotti A; Tessa M; Foco A; Oliaro A; Casadio C; Dei Poli M
    Radiol Med; 1996 Apr; 91(4):456-9. PubMed ID: 8643859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.
    Castoro C; Scarpa M; Cagol M; Ruol A; Cavallin F; Alfieri R; Zanchettin G; Rugge M; Ancona E
    Ann Surg Oncol; 2011 Dec; 18(13):3743-54. PubMed ID: 21556952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Split-course concomitant radiochemotherapy plus surgery vs. surgery alone in squamous cell carcinoma of the esophagus. A non-randomized retrospective study of 184 patients].
    Malhaire JP; Lozac'h P; Simon H; Labat JP; Topart P; Lucas B; Metges JP; Lamezec B
    Bull Cancer; 1997 Apr; 84(4):357-67. PubMed ID: 9238158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of definitive chemo-radiotherapy for esophageal cancer with supra-clavicular node metastasis based on CT in a single institutional retrospective study: a propensity score matching analysis.
    Xu HY; Wu SX; Luo HS; Chen CY; Lin LX; Huang HC
    Radiat Oncol; 2018 Oct; 13(1):200. PubMed ID: 30326912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases.
    Xiao ZF; Yang ZY; Miao YJ; Wang LH; Yin WB; Gu XZ; Zhang DC; Sun KL; Chen GY; He J
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):82-90. PubMed ID: 15850906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of number of [(18)F]fluorodeoxyglucose-PET-positive lymph nodes on survival of patients receiving neoadjuvant chemotherapy and surgery for oesophageal cancer.
    Miyata H; Yamasaki M; Makino T; Tatsumi M; Miyazaki Y; Takahashi T; Kurokawa Y; Takiguchi S; Mori M; Doki Y
    Br J Surg; 2016 Jan; 103(1):97-104. PubMed ID: 26506079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patients.
    Chak A; Canto MI; Cooper GS; Isenberg G; Willis J; Levitan N; Clayman J; Forastiere A; Heath E; Sivak MV
    Cancer; 2000 Apr; 88(8):1788-95. PubMed ID: 10760753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Curative non-surgical combined treatment of squamous cell carcinoma of the oesophagus.
    Zenone T; Romestaing P; Lambert R; Gerard JP
    Eur J Cancer; 1992; 28A(8-9):1380-6. PubMed ID: 1515254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accurate lymph node assessment prior to trimodality therapy for esophageal carcinoma.
    Suntharalingam M; Haas ML; Sonett JR; Doyle LA; Hausner PF; Schuetz J; Greenwald B; Krasna MJ
    Cancer J; 2001; 7(6):509-15. PubMed ID: 11769864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic relevance of serial endoscopic ultrasound after chemoradiation in esophageal cancer.
    Bohle W; Kasper M; Zoller WG
    Dis Esophagus; 2017 Oct; 30(10):1-8. PubMed ID: 28859390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus.
    Ishikura S; Nihei K; Ohtsu A; Boku N; Hironaka S; Mera K; Muto M; Ogino T; Yoshida S
    J Clin Oncol; 2003 Jul; 21(14):2697-702. PubMed ID: 12860946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
    Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors of radiotherapy in patients with node-positive thoracic esophageal squamous cell carcinoma after radical surgery.
    Lu JC; Tao H; Chen ZZ; Qian PD
    Dis Esophagus; 2009; 22(6):490-5. PubMed ID: 19191849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
    Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
    Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of neoadjuvant chemotherapy on primary tumor and lymph node metastasis in esophageal squamous cell carcinoma: additive association with prognosis.
    Akita H; Doki Y; Yano M; Miyata H; Miyashiro I; Ohigashi H; Ishikawa O; Nishiyama A; Imaoka S
    Dis Esophagus; 2009; 22(4):291-7. PubMed ID: 19021686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of prognosis after trimodal therapy in patients with locally advanced squamous cell carcinoma of the oesophagus.
    Stahl M; Lehmann N; Walz MK; Stuschke M; Wilke H
    Eur J Cancer; 2012 Nov; 48(16):2977-82. PubMed ID: 22503151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The number of lymph node metastases influences survival and International Union Against Cancer tumor-node-metastasis classification for esophageal squamous cell carcinoma.
    Zhang HL; Chen LQ; Liu RL; Shi YT; He M; Meng XL; Bai SX; Ping YM
    Dis Esophagus; 2010 Jan; 23(1):53-8. PubMed ID: 19392846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cervical nodal metastases of unresectable thoracic esophageal squamous cell carcinoma: characteristics of long-term survivors after concurrent chemoradiotherapy.
    Liu H; Lu L; Zhu Q; Hao Y; Mo Y; Liu M; Hu Y; Cui N; Rong T
    Radiother Oncol; 2011 May; 99(2):181-6. PubMed ID: 21620504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Number and location of positive nodes, postoperative radiotherapy, and survival after esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma.
    Chen J; Pan J; Zheng X; Zhu K; Li J; Chen M; Wang J; Liao Z
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):475-82. PubMed ID: 20934269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The combined radio-chemotherapy of inoperable esophageal cancer].
    Köhler AH
    Radiobiol Radiother (Berl); 1990; 31(6):497-502. PubMed ID: 1714081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.